PFM Health Sciences’s Esperion Therapeutics ESPR Stock Holding History

PFM Health Sciences’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,555,112	Closed	-$72.3M	–	82
2019 Q2	$72.3M	Sell	1,555,112 -71,967	-4%	-$3.38M	1.76%	23
2019 Q1	$65.3M	Sell	1,627,079 -251,924	-13%	-$11.3M	1.78%	28
2018 Q4	$86.4M	Sell	1,879,003 -91,131	-5%	-$4.39M	2.5%	8
2018 Q3	$87.4M	Sell	1,970,134 -490,023	-20%	-$22.5M	1.49%	26
2018 Q2	$96.4M	Buy	2,460,157 +1,330,159	+118%	+$67.2M	1.79%	15
2018 Q1	$81.7M	Buy	1,129,998 +259,896	+30%	+$19.1M	1.76%	20
2017 Q4	$57.3M	Buy	870,102 +321,420	+59%	+$17.3M	1.45%	31
2017 Q3	$27.5M	Buy	548,682 +334,702	+156%	+$16.1M	0.68%	60
2017 Q2	$9.9M	Buy	+213,980	New	+$7.87M	0.29%	77

Other funds holding ESPR

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return